2026 NPPES data Oncology Registered Nurse NPI 1942507603 FNP-BC
Verify on CMS →

AMELIA CASE, FNP-BC

Oncology Registered Nurse in MAYNARDVILLE, Tennessee. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 313 beneficiaries · Oncology Registered Nurse avg: 555
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.5K
68 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: AMELIA CASE, FNP-BC is a Oncology Registered Nurse ([object Object]) practicing in MAYNARDVILLE, Tennessee with a Medicare Part D prescribing footprint of 6K claims across 313 beneficiaries — 18% brand-name prescribing . Industry payments of $1.5K across 68 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

AMELIA CASE, FNP-BC filed 5,684 Medicare Part D claims in 2023 as a Oncology Registered Nurse in MAYNARDVILLE, Tennessee, prescribing 82% generic.

6K
Part D claims, 2023
82%
generic prescribing
$1.5K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMELIA CASE, FNP-BC at a glance

Quality data not reported

NPI registry status

Active

Issued 02/16/2011

NPI 1942507603

Primary specialty

Oncology Registered Nurse

Niche

857 US NPIs in this specialty

Medicare Part D claims

5,684 924% vs specialty avg

2023 prescription claims

Specialty avg: 555

Specialty distribution in Tennessee

How Oncology Registered Nurse compares to other specialties among Tennessee providers

Tennessee providers

Oncology Registered Nurse share within Tennessee

1. Oncology Registered Nurse42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oncology Registered Nurse share within Tennessee

Specialty board-certification context

Estimated specialty board-certified rate — Oncology Registered Nurse (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oncology Registered Nurse ABMS/AOA estimate

Est. board-certified rate (Oncology Registered Nurse) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oncology Registered Nurse) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMELIA CASE, FNP-BC is a Oncology Registered Nurse provider practicing in MAYNARDVILLE, Tennessee, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: FNP-BC. NPI: 1942507603. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AMELIA CASE, FNP-BC appears in the CMS NPPES registry as a Oncology Registered Nurse provider holding FNP-BC credentials at 149 DURHAM DR, MAYNARDVILLE, TN, 37807, with a listed phone of (865) 992-2221. NPI 1942507603 was issued on 02/16/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CASE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,684 prescription claims written by this provider, covering 313 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 3.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oncology Registered Nurse is a narrow specialty nationwide, with 857 enrolled providers across 50 states and an average of 555 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

149 DURHAM DR
MAYNARDVILLE, TN 37807

Provider Details

NPI 1942507603
Specialty Oncology Registered Nurse
Credentials FNP-BC
Gender Female
NPI Issued 02/16/2011

Hospital and facility affiliations

Facilities where AMELIA CASE, FNP-BC bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SUMMIT MEDICAL GROUP, PLLC
KNOXVILLE, TN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMELIA CASE, FNP-BC. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

Otsuka America Pharmaceutical, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

AMELIA CASE, FNP-BC — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 5,684 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,684
Total Claims
$1.0M
Total Drug Cost
313
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
11,849
Total Day Supply
344,369
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$934K
Generic Drug Cost
$92K
Opioid Claims
204 (3.6% rate)
Antibiotic Claims
149

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.51
Gender Split
72% female / 28% male
Age Distribution
<65: 70, 65-74: 142, 75-84: 84, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
191
Omeprazole
167
Albuterol Sulfate Hfa
Albuterol Sulfate
165
Gabapentin
150
Amlodipine Besylate
143
Rosuvastatin Calcium
125
Pravastatin Sodium
113
Alprazolam
109
Fluticasone Propionate
107
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
104

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oncology Registered Nurse Overview

How AMELIA CASE, FNP-BC fits within the Oncology Registered Nurse landscape nationally.

857
Oncology Registered Nurse Providers in US
50
States with Oncology Registered Nurse
555
Avg Claims per Provider

AMELIA CASE, FNP-BC's 5,684 claims are above the specialty average of 555.

Nearby Oncology Registered Nurse Providers in Tennessee

Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as CASE.

Compare Oncology Registered Nurse nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMELIA CASE, FNP-BC's specialty?
AMELIA CASE, FNP-BC specializes in Oncology Registered Nurse and practices in MAYNARDVILLE, Tennessee. Credentials: FNP-BC.
How much does AMELIA CASE, FNP-BC prescribe under Medicare Part D?
In 2023, AMELIA CASE, FNP-BC wrote 5,684 Medicare Part D claims totaling $1.0M in drug costs for 313 beneficiaries.
Where is AMELIA CASE, FNP-BC located?
AMELIA CASE, FNP-BC is located at 149 DURHAM DR, MAYNARDVILLE, TN, 37807. Phone: (865) 992-2221.
What is AMELIA CASE, FNP-BC's NPI number?
AMELIA CASE, FNP-BC's National Provider Identifier (NPI) is 1942507603, issued on 02/16/2011.
Does AMELIA CASE, FNP-BC prescribe more brand-name or generic drugs?
AMELIA CASE, FNP-BC's prescribing is 18% brand-name and 82% generic drugs by claim count, with $934K in brand drug costs.
Does AMELIA CASE, FNP-BC prescribe opioids?
Yes, AMELIA CASE, FNP-BC had 204 opioid claims in 2023 with an opioid prescribing rate of 3.6%.
How many Oncology Registered Nurse providers are there in the US?
There are 857 Oncology Registered Nurse providers across 50 states in the US. The average Oncology Registered Nurse provider writes 555 Medicare Part D claims per year.
What drugs does AMELIA CASE, FNP-BC prescribe most often?
Based on 2023 Medicare Part D data, AMELIA CASE, FNP-BC's most frequently prescribed drugs include Levothyroxine Sodium, Omeprazole, Albuterol Sulfate Hfa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMELIA CASE, FNP-BC accept Medicare?
AMELIA CASE, FNP-BC appears in CMS Medicare data with 5,684 Part D claims and 313 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMELIA CASE, FNP-BC's credentials?
AMELIA CASE, FNP-BC's NPI is 1942507603 with credentials FNP-BC. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology